Name: BIOTEST AG-VORZUGSAKTIEN (BIO3) Stock
Brand: BIOTEST AG-VORZUGSAKTIEN
Rating: 3.5 (3 reviews)

Question 1

What does BIOTEST AG-VORZUGSAKTIEN do?

Accepted Answer

Biotest AG is a DE-based company operating in Biotechnology industry. The company is headquartered in Dreieich, Hessen and currently employs 2,495 full-time employees.  Biotest AG is a Germany-based provider of plasma proteins and biological drugs. The Company, with a chain that extends from pre-clinical and clinical development to worldwide marketing and distribution, mainly specializes in the areas of clinical immunology, hematology, and intensive care medicine. The company develops, manufactures, and markets immunoglobulin, coagulation factors, and albumins based on human blood plasma. These are used for diseases of the immune and hematopoietic systems. In addition, the Company develops monoclonal antibodies in the indications of cancer of plasma cells and systemic lupus erythematosus, which are produced by recombinant technologies.

Question 2

What is the current price of BIO3 stock?

Accepted Answer

The current stock price of BIO3.DE is 30 EUR.

Question 3

Does BIOTEST AG-VORZUGSAKTIEN pay dividends?

Accepted Answer

BIOTEST AG-VORZUGSAKTIEN (BIO3.DE) has a dividend yield of 0.09%. The yearly dividend amount is currently 0.04.

Question 4

What is the ChartMill rating of BIOTEST AG-VORZUGSAKTIEN stock?

Accepted Answer

BIO3.DE has a ChartMill Technical rating of 2 out of 10 and a ChartMill Fundamental rating of 4 out of 10.

Question 5

What is the GICS sector and industry of BIO3 stock?

Accepted Answer

BIOTEST AG-VORZUGSAKTIEN (BIO3.DE) operates in the Health Care sector and the Biotechnology industry.

Question 6

How is the valuation of BIOTEST AG-VORZUGSAKTIEN (BIO3.DE) based on its PE ratio?

Accepted Answer

BIOTEST AG-VORZUGSAKTIEN (BIO3.DE) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.65).

Question 7

Can you provide the market cap for BIOTEST AG-VORZUGSAKTIEN?

Accepted Answer

BIOTEST AG-VORZUGSAKTIEN (BIO3.DE) has a market capitalization of 1.19B EUR. This makes BIO3.DE a Small Cap stock.

BIOTEST AG-VORZUGSAKTIEN (BIO3.DE) Stock Price, Forecast & Analysis

BIO3.DE Latest News, Press Relases and Analysis